FSD Pharma Inc (HUGE)
0.30
-0.01
(-3.23%)
USD |
NASDAQ |
May 31, 16:00
0.30
0.00 (0.00%)
After-Hours: 20:00
FSD Pharma Enterprise Value: 10.62M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 10.62M |
| May 30, 2024 | 11.05M |
| May 29, 2024 | 11.34M |
| May 28, 2024 | 12.52M |
| May 24, 2024 | 12.72M |
| May 23, 2024 | 13.10M |
| May 22, 2024 | 12.31M |
| May 21, 2024 | 12.29M |
| May 20, 2024 | 12.73M |
| May 17, 2024 | 11.42M |
| May 16, 2024 | 11.26M |
| May 15, 2024 | 11.70M |
| May 14, 2024 | 12.65M |
| May 13, 2024 | 13.37M |
| May 10, 2024 | 11.74M |
| May 09, 2024 | 12.19M |
| May 08, 2024 | 12.08M |
| May 07, 2024 | 12.71M |
| May 06, 2024 | 13.03M |
| May 03, 2024 | 12.95M |
| May 02, 2024 | 12.86M |
| May 01, 2024 | 13.17M |
| April 30, 2024 | 14.47M |
| April 29, 2024 | 15.70M |
| April 26, 2024 | 17.40M |
| Date | Value |
|---|---|
| April 25, 2024 | 17.11M |
| April 24, 2024 | 16.56M |
| April 23, 2024 | 16.76M |
| April 22, 2024 | 17.76M |
| April 19, 2024 | 16.86M |
| April 18, 2024 | 16.81M |
| April 17, 2024 | 16.63M |
| April 16, 2024 | 18.21M |
| April 15, 2024 | 19.13M |
| April 12, 2024 | 22.13M |
| April 11, 2024 | 22.90M |
| April 10, 2024 | 22.66M |
| April 09, 2024 | 22.66M |
| April 08, 2024 | 23.06M |
| April 05, 2024 | 23.44M |
| April 04, 2024 | 24.08M |
| April 03, 2024 | 24.67M |
| April 02, 2024 | 25.08M |
| April 01, 2024 | 25.95M |
| March 28, 2024 | 25.39M |
| March 27, 2024 | 24.42M |
| March 26, 2024 | 24.06M |
| March 25, 2024 | 22.86M |
| March 22, 2024 | 23.24M |
| March 21, 2024 | 24.22M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-2.311M
Minimum
Mar 22 2022
198.23M
Maximum
Jun 12 2019
32.74M
Average
24.67M
Median
Apr 06 2020
Enterprise Value Benchmarks
| Acasti Pharma Inc | 0.5379M |
| Aurinia Pharmaceuticals Inc | 424.68M |
| Edesa Biotech Inc | 11.48M |
| Lexaria Bioscience Corp | 45.09M |
| Xenon Pharmaceuticals Inc | 2.175B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.903M |
| Total Expenses (Quarterly) | 2.253M |
| EPS Diluted (Quarterly) | -0.05 |
| Earnings Yield | -86.67% |
| Normalized Earnings Yield | -1146.68 |